Trial intelligence / Profile preview

Double-blind, placebo-controlled Phase 2 study of PSD506 in overactive bladder

2006-001334-40Phase 2Terminated

Sponsor
Plethora Solutions
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in overactive bladder (OAB) comparing PSD506 with Placebo (2 arms). Started Aug 2006; status: terminated.

02

Drugs

PSD506
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on 2006-001334-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001334-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call